Serum cholesterol levels, HMG-CoA reductase inhibitors and the risk of intracerebral haemorrhage. The Multicenter Study on Cerebral Haemorrhage in Italy (MUCH-Italy)

Risk Factors, Stroke Prevention Treatments, and Prevalence of Cerebral Microbleeds in the Framingham Heart Study

(2014) José Rafael Romero et al.   STROKE

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Obesity and the Risk of Intracerebral Hemorrhage

(2013) Alessandro Pezzini et al.   STROKE

Apolipoprotein E, Statins, and Risk of Intracerebral Hemorrhage

(2013) Daniel Woo et al.   STROKE

Cholesterol Levels and Risk of Hemorrhagic Stroke

(2013) Xiang Wang et al.   STROKE

Statin Use and Microbleeds in Patients With Spontaneous Intracerebral Hemorrhage

(2012) Diogo C. Haussen et al.   STROKE

Statin Therapy and the Risk of Intracerebral Hemorrhage

(2012) James S. McKinney et al.   STROKE

Statins and Intracerebral Hemorrhage

(2011) Daniel G. Hackam et al.   CIRCULATION

Distribution of short and lifetime risks for cardiovascular disease in Italians

(2011) Augusto Di Castelnuovo et al.   European Journal of Preventive Cardiology

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Cerebral Amyloid Angiopathy: A Common Cause of Cerebral Hemorrhage

(2009) A. Pezzini et al.   CURRENT MEDICINAL CHEMISTRY

Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention

(2009) Pierre Amarenco et al.   LANCET NEUROLOGY

New Insights into the Pleiotropic Effects of Statins for Stroke Prevention

(2009) Alessandro Pezzini et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY